The amount of money that biomedical researchers receive from drug companies outstrips grants from the federal government, $55 billion versus $36 billion, respectively, reports the Los Angeles Times. With this funding, drug companies build close relationships with universities and their researchers who still appear to be impartial as they serve on committees that pen tre

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.